A detailed history of Capital World Investors transactions in Zai Lab LTD stock. As of the latest transaction made, Capital World Investors holds 6,435,383 shares of ZLAB stock, worth $172 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,435,383
Previous 5,307,939 21.24%
Holding current value
$172 Million
Previous $92 Million 68.88%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.25 - $24.14 $18.3 Million - $27.2 Million
1,127,444 Added 21.24%
6,435,383 $155 Million
Q2 2024

Aug 13, 2024

SELL
$13.72 - $21.55 $5.16 Million - $8.11 Million
-376,241 Reduced 6.62%
5,307,939 $92 Million
Q1 2024

May 14, 2024

BUY
$15.95 - $26.8 $7.42 Million - $12.5 Million
465,337 Added 8.92%
5,684,180 $91.1 Million
Q3 2023

Nov 13, 2023

SELL
$22.72 - $31.49 $107,352 - $148,790
-4,725 Reduced 0.09%
5,218,843 $127 Million
Q2 2023

Aug 11, 2023

BUY
$25.3 - $39.67 $14.1 Million - $22.1 Million
557,699 Added 11.95%
5,223,568 $145 Million
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $124 Million - $197 Million
4,095,725 Added 718.37%
4,665,869 $155 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $359,031 - $542,641
-10,498 Reduced 1.81%
570,144 $19.5 Million
Q2 2022

Aug 15, 2022

SELL
$23.14 - $49.68 $29.3 Million - $63 Million
-1,268,216 Reduced 68.59%
580,642 $20.1 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $62.1 Million - $144 Million
-2,235,387 Reduced 54.73%
1,848,858 $81.3 Million
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $141 Million - $270 Million
-2,562,492 Reduced 38.55%
4,084,245 $257 Million
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $246 Million - $418 Million
-2,344,731 Reduced 26.08%
6,646,737 $701 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $76.7 Million - $110 Million
612,742 Added 7.31%
8,991,468 $1.59 Billion
Q1 2021

May 14, 2021

SELL
$126.27 - $191.71 $21.8 Million - $33.1 Million
-172,716 Reduced 2.02%
8,378,726 $1.12 Billion
Q4 2020

Feb 12, 2021

BUY
$81.94 - $135.34 $132 Million - $217 Million
1,604,838 Added 23.1%
8,551,442 $1.16 Billion
Q3 2020

Nov 13, 2020

BUY
$73.3 - $89.48 $75 Million - $91.6 Million
1,023,276 Added 17.28%
6,946,604 $578 Million
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $2.22 Million - $3.76 Million
45,569 Added 0.78%
5,923,328 $486 Million
Q1 2020

May 15, 2020

BUY
$39.1 - $62.9 $230 Million - $370 Million
5,877,759 New
5,877,759 $303 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.62B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.